Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Van Praet

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Rheumatology|February 13, 2010
Validation of a new screening strategy for anti-extractable nuclear antigen antibodiesJ T Van Praet, B Vander Cruyssen, C Bonroy, et al.
Annals of the Rheumatic Diseases|December 24, 2008
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological studyV Smith, J T Van Praet, B Vandooren, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|February 13, 2010
Validation of a new screening strategy for anti-extractable nuclear antigen antibodiesJ T Van Praet, B Vander Cruyssen, C Bonroy, et al.
Annals of the Rheumatic Diseases|December 24, 2008
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological studyV Smith, J T Van Praet, B Vandooren, et al.
Pageof 1